192 related articles for article (PubMed ID: 18474601)
21. TRIM10 binds to IFN-α/β receptor 1 to negatively regulate type I IFN signal transduction.
Guo M; Cao W; Chen S; Tian R; Wang L; Liu Q; Zhang L; Wang Z; Zhao M; Lu Q; Zhu H
Eur J Immunol; 2021 Jul; 51(7):1762-1773. PubMed ID: 33811647
[TBL] [Abstract][Full Text] [Related]
22. A hot spot on interferon α/β receptor subunit 1 (IFNAR1) underpins its interaction with interferon-β and dictates signaling.
de Weerd NA; Matthews AY; Pattie PR; Bourke NM; Lim SS; Vivian JP; Rossjohn J; Hertzog PJ
J Biol Chem; 2017 May; 292(18):7554-7565. PubMed ID: 28289093
[TBL] [Abstract][Full Text] [Related]
23. SCF(HOS) ubiquitin ligase mediates the ligand-induced down-regulation of the interferon-alpha receptor.
Kumar KG; Tang W; Ravindranath AK; Clark WA; Croze E; Fuchs SY
EMBO J; 2003 Oct; 22(20):5480-90. PubMed ID: 14532120
[TBL] [Abstract][Full Text] [Related]
24. The antiviral action of interferon is potentiated by removal of the conserved IRTAM domain of the IFNAR1 chain of the interferon alpha/beta receptor: effects on JAK-STAT activation and receptor down-regulation.
Basu L; Yang CH; Murti A; Garcia JV; Croze E; Constantinescu SN; Mullersman JE; Pfeffer LM
Virology; 1998 Mar; 242(1):14-21. PubMed ID: 9501047
[TBL] [Abstract][Full Text] [Related]
25. Luteolin sensitizes the antiproliferative effect of interferon α/β by activation of Janus kinase/signal transducer and activator of transcription pathway signaling through protein kinase A-mediated inhibition of protein tyrosine phosphatase SHP-2 in cancer cells.
Tai Z; Lin Y; He Y; Huang J; Guo J; Yang L; Zhang G; Wang F
Cell Signal; 2014 Mar; 26(3):619-28. PubMed ID: 24333668
[TBL] [Abstract][Full Text] [Related]
26. The Stat3-activating Tyk2 V678F mutant does not up-regulate signaling through the type I interferon receptor but confers ligand hypersensitivity to a homodimeric receptor.
Gakovic M; Ragimbeau J; Francois V; Constantinescu SN; Pellegrini S
J Biol Chem; 2008 Jul; 283(27):18522-9. PubMed ID: 18456658
[TBL] [Abstract][Full Text] [Related]
27. Type I IFN receptor controls activated TYK2 in the nucleus: implications for EAE therapy.
Ahmed CM; Noon-Song EN; Kemppainen K; Pascalli MP; Johnson HM
J Neuroimmunol; 2013 Jan; 254(1-2):101-9. PubMed ID: 23110939
[TBL] [Abstract][Full Text] [Related]
28. Mammalian casein kinase 1alpha and its leishmanial ortholog regulate stability of IFNAR1 and type I interferon signaling.
Liu J; Carvalho LP; Bhattacharya S; Carbone CJ; Kumar KG; Leu NA; Yau PM; Donald RG; Weiss MJ; Baker DP; McLaughlin KJ; Scott P; Fuchs SY
Mol Cell Biol; 2009 Dec; 29(24):6401-12. PubMed ID: 19805514
[TBL] [Abstract][Full Text] [Related]
29. Tyrosine kinase 2 promotes sepsis-associated lethality by facilitating production of interleukin-27.
Bosmann M; Strobl B; Kichler N; Rigler D; Grailer JJ; Pache F; Murray PJ; Müller M; Ward PA
J Leukoc Biol; 2014 Jul; 96(1):123-31. PubMed ID: 24604832
[TBL] [Abstract][Full Text] [Related]
30. Structural basis of recognition of interferon-α receptor by tyrosine kinase 2.
Wallweber HJ; Tam C; Franke Y; Starovasnik MA; Lupardus PJ
Nat Struct Mol Biol; 2014 May; 21(5):443-8. PubMed ID: 24704786
[TBL] [Abstract][Full Text] [Related]
31. TYK2 Variants in B-Acute Lymphoblastic Leukaemia.
Turrubiartes-Martínez E; Bodega-Mayor I; Delgado-Wicke P; Molina-Jiménez F; Casique-Aguirre D; González-Andrade M; Rapado I; Camós M; Díaz-de-Heredia C; Barragán E; Ramírez-Orellana M; Aguado B; Figuera Á; Martínez-López J; Fernández-Ruiz E
Genes (Basel); 2020 Nov; 11(12):. PubMed ID: 33260630
[TBL] [Abstract][Full Text] [Related]
32. Definition of the interferon-alpha receptor-binding domain on the TYK2 kinase.
Yan H; Piazza F; Krishnan K; Pine R; Krolewski JJ
J Biol Chem; 1998 Feb; 273(7):4046-51. PubMed ID: 9461596
[TBL] [Abstract][Full Text] [Related]
33. Comparable potency of IFNalpha2 and IFNbeta on immediate JAK/STAT activation but differential down-regulation of IFNAR2.
Marijanovic Z; Ragimbeau J; van der Heyden J; Uzé G; Pellegrini S
Biochem J; 2007 Oct; 407(1):141-51. PubMed ID: 17627610
[TBL] [Abstract][Full Text] [Related]
34. Ligand-independent interaction of the type I interferon receptor complex is necessary to observe its biological activity.
Krause CD; Digioia G; Izotova LS; Xie J; Kim Y; Schwartz BJ; Mirochnitchenko OV; Pestka S
Cytokine; 2013 Oct; 64(1):286-97. PubMed ID: 23830819
[TBL] [Abstract][Full Text] [Related]
35. A BRISC-SHMT complex deubiquitinates IFNAR1 and regulates interferon responses.
Zheng H; Gupta V; Patterson-Fortin J; Bhattacharya S; Katlinski K; Wu J; Varghese B; Carbone CJ; Aressy B; Fuchs SY; Greenberg RA
Cell Rep; 2013 Oct; 5(1):180-93. PubMed ID: 24075985
[TBL] [Abstract][Full Text] [Related]
36. Identification of an indispensable role for tyrosine kinase 2 in CTL-mediated tumor surveillance.
Simma O; Zebedin E; Neugebauer N; Schellack C; Pilz A; Chang-Rodriguez S; Lingnau K; Weisz E; Putz EM; Pickl WF; Felzmann T; Müller M; Decker T; Sexl V; Stoiber D
Cancer Res; 2009 Jan; 69(1):203-11. PubMed ID: 19118004
[TBL] [Abstract][Full Text] [Related]
37. Receptor density is key to the alpha2/beta interferon differential activities.
Moraga I; Harari D; Schreiber G; Uzé G; Pellegrini S
Mol Cell Biol; 2009 Sep; 29(17):4778-87. PubMed ID: 19564411
[TBL] [Abstract][Full Text] [Related]
38. The human papilloma virus (HPV)-18 E6 oncoprotein physically associates with Tyk2 and impairs Jak-STAT activation by interferon-alpha.
Li S; Labrecque S; Gauzzi MC; Cuddihy AR; Wong AH; Pellegrini S; Matlashewski GJ; Koromilas AE
Oncogene; 1999 Oct; 18(42):5727-37. PubMed ID: 10523853
[TBL] [Abstract][Full Text] [Related]
39. Respirovirus C protein inhibits activation of type I interferon receptor-associated kinases to block JAK-STAT signaling.
Kitagawa Y; Yamaguchi M; Kohno M; Sakai M; Itoh M; Gotoh B
FEBS Lett; 2020 Mar; 594(5):864-877. PubMed ID: 31705658
[TBL] [Abstract][Full Text] [Related]
40. Chaperone-Mediated Autophagy Targets IFNAR1 for Lysosomal Degradation in Free Fatty Acid Treated HCV Cell Culture.
Kurt R; Chandra PK; Aboulnasr F; Panigrahi R; Ferraris P; Aydin Y; Reiss K; Wu T; Balart LA; Dash S
PLoS One; 2015; 10(5):e0125962. PubMed ID: 25961570
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
